Abstract
Invasive Gram-negative bacterial infections often result in the development of septic shock. This syndrome is always serious, and often fatal. While the best estimates of the incidence of Gram-negative sepsis in the United States are almost a decade old, Gram-negative sepsis may account for as many as 50000 deaths annually [1, 2]. Once patients exhibit the septic shock syndrome, almost 40% will die. A major challenge is identifying drug targets that can be manipulated therapeutically in order to reduce the high mortahty associated with sepsis.
Keywords
- Chinese Hamster Ovary Cell
- Pelvic Inflammatory Disease
- Cholesterol Ester Transfer Protein
- Macrophage Scavenger Receptor
- Identify Drug Target
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457–469
Martin MA (1991) Epidemiology and dinical aspects of Gram-negative sepsis. Infect Dis Clin North Am 5:739–752
Raetz CRH (1990) Biochemistry of endotoxins. Annu Rev Biochem 59:129–170
Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267:26–31
Strain SM, Fesik SW, Armitage IM (1983) Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon-43 nuclear magnetic resonance. J Biol Chem 258:2906–2910
Imoto M, Kusumoto S, Shiba T, et al (1983) Chemical structure of E. coli Lipid A: Linkage site of acyl groups in the disaccharide backbone. Tetrahedron Lett 24:4017–4020
Haworth R, Piatt N, Keshav S, et al (1997) The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 186:1431–1439
Hailman E, Lichenstein HS, Wurfel MM, et al (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD 14. J Exp Med 179:269–277
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431–1433
Wright SD, Ramos RA, Hermanowski-Vosatka AH, Rockwell P, Detmers PA (1991 ) Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14. J Exp Med 173:1281–1286
Lynn WA, Raetz CR, Qureshi N, Golenbock DT (1991) Lipopolysaccharide-induced stimulation of GDI lb/CD 18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J Immunol 147:3072–3079
Kitchens RL, Ulevitch RJ, Munford RS (1992) Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 176:485–494
Kirkland T N, Finley F, Leturcq D, et al (1993) Analysis of Hpopolysaccharide binding by CD 14. J Biol Chem 268:24818–24823
Bazil V, Baudys M, Hilgert I, et al (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD 14. Mol Immunol 26: 657–662
Frey EA, Miller DS, Jahr TG, et al (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176:1665–1671
Arditi M, Zhou J, Dorio R, Rong GW, Goyert SM, Kim KS (1993) Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun 61:3149–3156
Haziot A, Rong GW, Silver J, Goyert SM (1993) Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 151:1500–1507
Pugin J, Schurer MC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharidebinding protein and soluble CD 14. Proc Natl Acad Sci USA 90:2744–2748
Lee J-D, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ (1992) Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 175:1697–1705
Golenbock D, Liu Y, Millham F, Freeman M, Zoeller R (1993) Surface expression of human CD 14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J Biol Chem 268:22055–22059
Viriyakosol S, Kirkland TN (1995) A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 270:361–368
Haziot A, Ferrero E, Konigen F, et al (1996) Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407–414
Haziot A, Ferrero E, Lin XY, Stewart CL, Goyert SM (1995) CD 14-deficient mice are exquisitely insensitive to the effects of LPS. Prog Clin Biol Res 392:349–351
Tobias PS, Soldau K, Ulevitch RJ (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164:777–793
Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 149:200–206
Hailman E, Vasselon T, Kelley M, et al (1996) Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 156:4384–4390
Park CT, Wright SD (1996) Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J Biol Chem 271:18054–18060
Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutrahzation of LPS. J Exp Med 180:1025–1035
Skarnes RC (1966) The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann NY Acad Sci 133:644–662
Skarnes RC (1968) In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity. J Bacteriol 95:2031–2034
Munford RS, Hall CL, Lipton JM, Dietschy JM (1982) Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 70:877–888
Ulevitch RJ, Johnston AR, Weinstein DB (1979) New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest 64:1516–1524
Gallay P, Barras C, Tobias PS, Calandra T, Glauser MP, Heumann D (1994) Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J Infect Dis 170:1319–1322
Galvano SE, Thompson WA, Marra MN, et al (1994) Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch Surg 129:220–226
Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopoly-saccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113–116
Martin TR, Rubenfeld GD, Ruzinski JT, et al (1997) Relationship between soluble CD 14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Grit Care Med 155:937–944
Ingalls RR, Golenbock DT (1995) CDllc/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 181:1473–1479
Ingalls RR, Arnaout MA, Golenbock DT (1997) Outside-in signaling by lipopolysaccharide through a tailless integrin. J Immunol 159:433–438
Wright SD, Tobias PS, Ulevitch RJ, Ramos RA (1989) Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 170:1231–1241
Ingalls RR, Monks BG, Savedra R Jr, et al (1998) GDI 1/CD18 and CD14 share a common lipid A signaling pathway. J Immunol 161:5413–5420
Lynn WA, Golenbock DT (1992) Lipopolysaccharide antagonists. Immunol Today 13: 271–276
Christ W, Asano O, Robidoux AL, et al (1995) E5531, a pure endotoxin antagonist of high potency. Science 268:80–83
Delude R, Savedra R, Zhao H, et al (1995) CD 14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Nad Acad Sci USA 92:9288–9292
Kitchens RL, Munford RS (1995) Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 270:9904–9910
Pugin J, Heumann ID, Tomasz A, et al (1994) CD 14 is a pattern recognition receptor. Immunity 1:509–516
Savedra R Jr, Delude RL, Ingalls RR, Fenton M J, Golenbock DT (1996) Mycobacterial lipoarabinomannan recognition requires a receptor hat shares components of the endotoxin signaling system. J Immunol 157:2549–2554
Belvin MP, Anderson KV (1996) A conserved signaling pathway: the Drosophila toll-dorsal pathway. Ann Rev Cell Dev Biol 12:393–416
Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF (1998) A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588–593
Yang RB, Mark MR, Gray A, et al (1998) Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284–288
Kirschning CJ, Wesche H, Ayres TM, Rothe M (1998) Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188:2091–2097
Poltorak A, He X, Smirnova I, et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: Mutations in Tlr4 gene. Science 282:2085–2088
Qureshi ST, Lariviere L, Leveque G, et al (1999) Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med 189:615–625
Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692
O’Neill LA, Greene C (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63: 650–657
Delude RL, Yoshimura A, Ingalls RR, Golenbock DT (1998) Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J Immunol 161:3001–3009
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lien, E., Heine, H., Golenbock, D.T. (2002). LPS Receptors. In: Marshall, J.C., Cohen, J. (eds) Immune Response in the Critically Ill. Update in Intensive Care Medicine, vol 31. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57210-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-57210-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42589-2
Online ISBN: 978-3-642-57210-4
eBook Packages: Springer Book Archive